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Supplementary figure 1: Sensitization models used in this study. (a)
We used an acute model of allergen-induced AHR by sensitizing mice on day 0 intratracheally with 100 µg of HDM extract, followed by challenge with the same dose of HDM on day 14. Airways measurements are performed 72h after last challenge (used in Fig. 1 ; 2a-f; 5a-d; and 6d-f and supplementary Fig. 6 ). Some mice also received anti-IL-17A or anti-C5aR antibodies (see Methods section). (b) Alternatively, we sensitized C3H/HeJ mice with HDM on days 0, and 14. In order to allow lung inflammation to resolve prior to administration of rIL-17A, mice were subsequently challenged with HDM, or HDM + rIL-17A on day 42 and airway measurements were performed 72h after (used in Fig. 2g) . (c) A/J mice were also exposed to 5 µg rIL-13, 5 µg rIL-17A or both intratracheally on days 0, 3, 6 and airway measurements were performed on day 7 (used in Fig.3a-h 
